Can't-Miss Highlights From ACG 2023: Part 1

This transcript has been edited for clarity.

Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia.

I'm just back from the American College of Gastroenterology (ACG) Annual Scientific Meeting in Vancouver, Canada. It was a smashing success, with approximately 7500 people attending, including 5500 on site and the remainder remotely.

The science was so outstanding that I've chosen to break this overview into two different segments. The order of the discussion follows no particular prioritization. It's simply designed to make it a little easier for you to follow in snippets and keep this relatively short.

Intestinal Ultrasound for IBD

The first study I'd like to highlight was about monitoring inflammatory bowel disease using intestinal ultrasound, an evolving technology performed at the bedside in real time.^[1]

This retrospective analysis comes to us from investigators at the University of Chicago Medicine, who followed patients at their clinic receiving upadacitinib and either undergoing routine intestinal ultrasound at their bedside or conventional management. Among patients undergoing intestinal ultrasound, clinical remission was defined by the measurement of bowel wall thickness ≤ 3 mm in the terminal ilium or the colon, and the absence of hyperemia by color Doppler signal.